ArticleACS omega2025
In Vitro Biodegradation and Biocompatibility of Bacterial Nanocellulose-Chitosan-Based Hydrogel Scaffolds for Bone Tissue Engineering.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effect of hUCMSC-seeded hydroxyapatite-chitosan scaffolds on immunomodulatory cytokine expression during alveolar socket healing: an in vivo study.Odontology · 2026Article
- Article
- Bacterial nanocellulose: biosynthesis, structural properties and vascular tissue engineering applications.Journal of materials science. Materials in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial nanocellulose (BNC) has many advantageous physicochemical characteristics, including high mechanical strength, high porosity, excellent water adsorption, and biocompatibility, making it a promising option for a wide range of biomedical applications. However, the limited biodegradability of BNC within the human body could reduce its utility in this field. In the present study, we investigated the in vitro biodegradability of a BNC composite of bacterial nanocellulose-chitosan-alginate-gelatin (BNC-CS-AG-GT). This BNC-CS-AG-GT hydrogel scaffold was shown to be gradually degraded during immersion in simulated body fluid (SBF) with the addition of lysozyme. Furthermore, the compressive strength of the BNC-CS-AG-GT hydrogel slowly decreased in correlation with incubation time: by 8 weeks of incubation in SBF, the compressive strength was reduced from ∼68 to ∼25 MPa, coupled with a 54% weight reduction. In cell culture, the BNC-CS-AG-GT scaffold was noncytotoxic. Cultivation of osteogenic MC3T3-E1 cells in osteogenic medium within a BNC-CS-AG-GT hydrogel for 4 weeks showed that the BNC-CS-AG-GT hydrogel supports cell adhesion and cell proliferation and promotes alkaline phosphatase (ALP) activity and mineralization in vitro. Moreover, BNC-CS-AG-GT exhibited strong antibacterial properties. The favorable biodegradability, mechanical properties, biocompatibility, and antibacterial activity of the BNC-CS-AG-GT hydrogel scaffold indicate that it has potential as a promising candidate for applications in bone tissue engineering. However, although these findings suggest that BNC-CS-AG-GT hydrogels have osteogenic potential in vitro, future additional studies in vivo and extended osteogenic differentiation assays are required to confirm the efficacy of BNC-CS-AG-GT scaffolds under physiological load conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.